| Outcome Measures: |
Primary: Occurence of adverse events, Adverse events - including unexpected adverse events, serious adverse events, drug-related adverse events, non-serious adverse drug reactions, adverse events of special interest, adverse events leading to discontinuation, adverse events by intensity/outcome of the events/causality), up to 24 weeks|Change from baseline in HbA1c after 12 weeks of treatment, at baseline, at week 12|Change from baseline in HbA1c after 24 weeks of treatment, at baseline, at week 24 | Secondary: Occurrence of treat to target effectiveness response after 12 weeks, effectiveness response is an Glucosylated Hemoglobin (HbA1c) under treatment of \< 7%, at week 12|Occurrence of treat to target effectiveness response after 24 weeks, effectiveness response is an Glucosylated Hemoglobin (HbA1c) under treatment of \< 7%, at week 24|Occurrence of relative effectiveness response after 12 weeks, relative effectiveness response is HbA1c lowering by at least 0.5%, at week 12|Occurrence of relative effectiveness response after 24 weeks, relative effectiveness response is HbA1c lowering by at least 0.5%, at week 24|Change from baseline in fasting plasma glucose (FPG) after 12 weeks of treatment, at baseline, at week 12|Change from baseline in fasting plasma glucose (FPG) after 24 weeks of treatment, at baseline, at week 24|Change from baseline in body weight after 12 weeks weeks of treatment, at baseline, at week 12|Change from baseline in body weight after 24 weeks weeks of treatment, at baseline, at week 24|Change from baseline in systolic blood pressure after 12 weeks of treatment, at baseline, at week 12|Change from baseline in diastolic blood pressure after 12 weeks of treatment, at baseline, at week 12|Change from baseline in systolic blood pressure after 24 weeks of treatment, at baseline, at week 24|Change from baseline in diastolic blood pressure after 24 weeks of treatment, at baseline, at week 24|Number of Participants with Final effectiveness evaluation, Final effectiveness will be evaluated as 'improved', 'unchanged', 'aggravated' or 'unassessable' based on the physician's evaluation of the overall participant's disease related factors after 24 weeks. 'Improved' will be if determined as there is any effect of maintaining or improving disease related factors, 'unchanged' will be if disease related factors have not been changed compared with before administration, and not determined as there is any effect of maintaining symptoms. 'Aggravated' will be if disease related factors are worse than before administration and 'unassessable' will be if it cannot be determined due to insufficient information collected. 'Improved', 'unchanged', 'aggravated' will be further categorized as 'effective' ('improved') and 'ineffective' ('unchanged' and 'aggravated')., up to 24 weeks
|
| Locations: |
Cheonan Chungmu Hospital, Cheonan-si, Chungcheongnam-do, 31181, Korea, Republic of|Woori-hospital, Bucheon-si, Gyeonggi-do, 14706, Korea, Republic of|Seo Jung Hwa Internal medicine, Gwangmyeong-si, Gyeonggi-do, 14248, Korea, Republic of|Samsung Internal medicine, Hanam-si, Gyeonggi-do, 12927, Korea, Republic of|Brrunmadi Orthopedics, Seongnam-si, Gyeonggi-do, 13182, Korea, Republic of|ST.Mary's Will Hospital, Seongnam-si, Gyeonggi-do, 13313, Korea, Republic of|21Chospital, Seongnam-si, Gyeonggi-do, 13577, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, Korea, Republic of|Dr.Yoon's Clinic, Gyeongsan-si, Gyeongsangbuk-do, 38657, Korea, Republic of|Yeongju gidok hospital, Yeongju-si, Gyeongsangbuk-do, 36096, Korea, Republic of|Seoul NIM Clinic, Changwon-si,, Gyeongsangnam-do,, 51595, Korea, Republic of|Choi Bongki Internal Medicine, Changwon-si, Gyeongsangnam-do, 51449, Korea, Republic of|Gyeongsang National Univ. Changwon Hospital, Changwon-si, Gyeongsangnam-do, 51472, Korea, Republic of|Chonnam National Univ. Hwasun Hospital, Hwasun-gun, Jeollanam-do, 58128, Korea, Republic of|Park Chang Hyun Clinic, Mokpo-si, Jeollanam-do, 58640, Korea, Republic of|Mokpo Gospel Internal Medicine Clinic, Mokpo-si, Jeollanam-do, 58664, Korea, Republic of|Park Il Jong Clinic, Mokpo-si, Jeollanam-do, 58707, Korea, Republic of|Yeosu Jeil Hospital, Yeosu-si, Jeollanam-do, 59677, Korea, Republic of|Yonsei Clinic, Busan, 46555, Korea, Republic of|MyungJi Medical Center, Busan, 46726, Korea, Republic of|Choi Won Rak Clinic, Busan, 49374, Korea, Republic of|Daejeon Endo Internal Medicine, Daejeon, 35220, Korea, Republic of|Good Morning Interanl medicine, Gwangju, 61675, Korea, Republic of|Park Clinic, Gwangju, 62258, Korea, Republic of|IBS Medical Clinic, Incheon, 22006, Korea, Republic of|Dream Internal Medicine Clinic, Jeju-si, 63083, Korea, Republic of|D&F Hospital, Seoul, 02089, Korea, Republic of|Kyung Hee University Medical Center, Seoul, 02447, Korea, Republic of|Yonsei Checkup Clinic, Seoul, 05719, Korea, Republic of|CBY Endocrine & Internal Medicine, Seoul, 08783, Korea, Republic of
|
